BetterScholar BetterScholar
8
Role
Title
Level Year L/R
🐜 Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): a randomised, double-blind, placebo-controlled, phase 3 trial
201 auth. R. Kate Kelley, M. Ueno, C. Yoo, Richard S Finn, J. Furuse, Z. Ren, T. Yau, H. Klümpen, Stephen L Chan, M. Ozaka, C. Verslype, M. Bouattour, Joon-Oh Park, O. Barajas, U. Pelzer, ... J. Valle, Li Yu, U. Malhotra, A. Siegel, J. Edeline, A. Vogel, M. Akce, Inmaculada Ales Diaz, G. Alves, Sumitra Anand, Ç. Arslan, J. Asselah, E. Assenat, F. Aubin, L. Bai, Y. Bai, Susan Bates, S. Begbie, I. Ben-Aharon, Nina Beri, M. Berres, J. Blanc, I. Borbath, R. Bordonaro, G. Brandi, Adam H. Burgoyne, Kritiya Butthongkomvong, M. Camandaroba, Ke Cao, M. Carballido, Stephan Lam Chan, Jen‐Shi Chen, Ming-Huang Chen, Xiaoming Chen, A. Cheng, T. Chiu, Hye Jin Choi, H. Chon, J. Collignon, A. C. Gracián, Sarah Davis, Ricardo Saraiva de Carvalho, D. J. Groot, A. Demols, J. Vos, M. Diab, J. Easaw, M. Eatock, Rawad Elias, F. Eskens, A. Falcone, P. Fernández, Richard S Finn, F. Franke, M. Furukawa, O. Gbolahan, K. Geboes, Keri-Lee Geneser, Zhimin Geng, R. Geva, R. Gillmore, T. Goetze, Hongfeng Gou, J. Grasselli, S. Gu, M. Gumus, N. H. Mohammad, C. Hao, H. Harputluoglu, H. Hatoum, V. Heinemann, W.K. Ho, C. Hsu, A. Hubert, J. Hwang, M. Inanc, S. Iseas, Vaishnavi Jeyasingam, P. Fonseca, W. Joubert, J. Juengsamarn, D. Kaen, Masashi Kanai, Stefan Kasper-Virchow, G. Kazemi, F. Kelleher, R. Kate Kelley, Jin Won Kim, Jong Gwang Kim, A. Abrahao, H. Klumpen, M. Kochenderfer, F. Kose, Ho-Ching Lam, Choong-kun Lee, Hyun Woo Lee, Margaret Lee, Myung Ah Lee, W. Lee, S. Sourd, Dongliang Li, Wei Li, Houjie Liang, T. Liang, Chun Sen Lim, B. Lingerfelt, Charles A. Lopez, J. Low, T. M. Mercadé, D. Malka, Y. Mao, G. Masi, S. McCune, R. McDermott, E. Mcwhirter, G. Mendez, M. Milella, Nobumasa Mizuno, T. Mizutani, C. Moniz, Luisa Morales, A. J. M. Martín, B. Nervi, N. Ngamphaiboon, S. Oh, B. Oksuzoglu, D. Outlaw, M. Ozguroglu, O. Ozyılkan, C. Painemal, Yueyin Pan, Chuang Peng, C. Pétorin, D. Pezet, D. Power, S. Qin, A. Roohullah, Hyewon Ryu, P. Salman, Mitsuhito Sasaki, R. Sasidharan, T. Satoh, K. Schulze, M. Scott-Brown, Rubén Segovia, Thomas Seufferlein, Salvatore Siena, I. Sinapi, C. Smolenschi, T. Song, A. Sookprasert, N. Soparattanapaisarn, N. Starling, S. Stein, S. Stemmer, Haichuan Su, R. Sugimoto, T. Suksombooncharoen, V. Tam, Ai Lian Tan, C. Tan, S. Tanasanvimon, G. Tonini, G. Tortora, A. Tsuji, Rodrigo Uribe, M. Venerito, H. Mata, A. Victorino, J. Wade, D. Waldschmidt, Lulu Wang, Wan Zamaniah Wan Isahk, Harpeet Wasan, R. Weschenfelder, Chun-yin Louisa Wong, Y. F. Wong, Ş. Yalçın, P. Weber, Xuezhong Yang, H. Yasui, O. Yazıcı, C. Yen, J. Ying, Wenchang Yu, Haitao Zhao
8 2023
8
🐜
🐜 Treatment decision-making among breast cancer patients in Malaysia
9 auth. Yong Hui Nies, F. Islahudin, W. Chong, N. Abdullah, F. Ismail, Ros Suzanna Ahmad Bustamam, ... Y. F. Wong, Jj Saladina, N. Mohamed Shah
4 2017
4
🐜
🐜 Effects of herbal medicine for xerostomia in head and neck cancer patients: an observational study in a tertiary cancer hospital
9 auth. Ren Jye Lim, Wan Najbah Nik Nabil, S. Y. Chan, Y. F. Wong, L. Han, J. Gong, ... K. Ho, Yee Siang Shew, Li Xu
3 2019
3
🐜
🦁 Treatment outcome for head and neck squamous cell carcinoma in a developing country: University Malaya Medical Centre, Malaysia from 2003-2010.
Y. F. Wong, M. Yusof, W. Z. Wan Ishak, A. Alip, V. Phua
3 2015
3
🦁
🐜 Prospective observational study on Pazopanib in patients treated for advanced or metastatic renal cell carcinoma in countries in Asia Pacific, North Africa, and Middle East regions: PARACHUTE study
13 auth. Erman Mustafa, Biswas Bivas, Danchaivijitr Pongwut, Lingwu Chen, Y. F. Wong, T. Hashem, Chun Sen Lim, B. Karabulut, Hsiao‐Jen Chung, C. Chikatapu, ... Sara Ingles, K. Slimane, R. Kanesvaran
3 2021
3
🐜
🐜 Correction to: Prospective observational study on Pazopanib in patients treated for advanced or metastatic renal cell carcinoma in countries in Asia Pacific, North Africa, and Middle East regions: PARACHUTE study
13 auth. M. Erman, B. Biswas, P. Danchaivijitr, Lingwu Chen, Y. F. Wong, T. Hashem, Chun Sen Lim, B. Karabulut, Hsiao‐Jen Chung, C. Chikatapu, ... Sara Ingles, K. Slimane, R. Kanesvaran
0 2021
0
🐜
🐜 Correction to: Prospective observational study on Pazopanib in patients treated for advanced or metastatic renal cell carcinoma in countries in Asia Pacific, North Africa, and Middle East regions: PARACHUTE study
13 auth. M. Erman, B. Biswas, P. Danchaivijitr, Lingwu Chen, Y. F. Wong, T. Hashem, Chun Sen Lim, B. Karabulut, Hsiao‐Jen Chung, C. Chikatapu, ... Sara Ingles, K. Slimane, R. Kanesvaran
0 2021
0
🐜
🐜 204P Prospective observational study on pazopanib in patients treated for advanced or metastatic renal cell carcinoma (RCC) in Asia, North Africa and Middle East countries: Final analysis of PARACHUTE study
13 auth. R. Kanesvaran, B. Biswas, P. Danchaivijitr, L. Chen, Y. F. Wong, T. Hashem, C. Lim, B. Karabulut, H. Chung, C. Chikatapu, ... S. Ingles, K. Silmane, M. Erman
0 2020
0
🐜